Macular Edema and Macular Degeneration Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Macular Edema and Macular Degeneration Market was valued at $8,301 million in 2020 and is projected to reach $16,530 million by 2028, registering a CAGR of 7% from 2022 to 2028.

Macular edema occurs when there is an abnormal leakage and accumulation of fluid in the macula from damaged blood vessels in the surrounding retina, which can damage vision and cause vision loss. There are two types of macular edema: cystic macular edema and diabetic macular edema. In addition, macular degeneration is a painless disease that causes central vision loss, which is a condition caused by retinal damage, and is a disease that mainly affects adults over 50 years of age or the elderly. There are two types of macular degeneration: wet macular degeneration and dry macular degeneration. The increasing aging population is a problem leading to more and more cases of macular edema and degeneration, contributing to the growth of the market. Treatments such as anti-vascular endothelial growth factor drugs for the treatment of diabetic macular edema, Lucentis (ranibizymab) and Avastin drugs for the treatment of macular degeneration play an important role in the growth of the global macular edema and macular degeneration market.

Market Segments

By Treatment Type    

• Drug Therapy 
• Laser Treatment 

By Application

• Macular Edema     
• Diabetic Macular Edema (DME)
• Cystoid Macular Edema (CME)
• Macular Degeneration     
• Dry age-related macular degeneration
• Wet age-related macular degeneration

Key Players

• F. Hoffmann-La Roche Ltd
• Novartis AG
• GlaxoSmithKline plc
• Allergan
• Regeneron Pharmaceuticals Inc
• Alimera Sciences
• Bausch Health Companies Inc.
• Kubota Pharmaceutical Holdings Co.
• Bayer AG

Scope of the Report

The research study analyzes the global Macular Edema and Macular Degeneration industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Macular Edema and Macular Degeneration Market Report

1. What was the Macular Edema and Macular Degeneration Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Macular Edema and Macular Degeneration Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Macular Edema and Macular Degeneration Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.